Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUS NASDAQ:AMED NASDAQ:BIOS NYSE:CHE NASDAQ:LHCG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$110.92-1.1%$112.46$88.96▼$136.72$2.06B0.81165,823 shs91,126 shsAMEDAmedisys$97.18-0.5%$95.84$82.15▼$98.95$3.19B0.94416,045 shs221,751 shsBIOSBioPlus Acquisition$10.80$10.80$10.05▼$11.68$209.10M0.01122,781 shs5,636 shsCHEChemed$459.69-1.3%$544.66$457.44▼$623.61$6.81B0.5112,311 shs95,700 shsLHCGLHC Group$169.81$166.14$115.32▼$169.84$5.27B0.43576,665 shsN/AA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare-1.14%-0.84%-1.57%+9.99%-6.62%AMEDAmedisys-0.50%+1.08%+0.31%+6.20%-0.74%BIOSBioPlus Acquisition0.00%0.00%0.00%0.00%-0.05%CHEChemed-1.41%-2.73%-16.30%-22.28%-12.86%LHCGLHC Group0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADUSAddus HomeCare4.9776 of 5 stars3.64.00.05.03.52.53.1AMEDAmedisys2.549 of 5 stars1.11.00.05.01.71.71.3BIOSBioPlus AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACHEChemed4.985 of 5 stars3.55.03.34.92.22.52.5LHCGLHC GroupN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 3.25Buy$142.5728.54% UpsideAMEDAmedisys 2.25Hold$100.753.67% UpsideBIOSBioPlus Acquisition 0.00N/AN/AN/ACHEChemed 3.00Buy$645.0040.31% UpsideLHCGLHC Group 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest LHCG, AMED, BIOS, ADUS, and CHE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/30/2025CHEChemedRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$674.00 ➝ $640.006/30/2025CHEChemedBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$708.00 ➝ $650.006/20/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.006/10/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$133.005/8/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$129.00 ➝ $133.004/28/2025CHEChemedRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$667.00 ➝ $674.004/22/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.004/16/2025AMEDAmedisysRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$100.00 ➝ $100.00(Data available from 7/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.15B1.77$5.33 per share20.82$53.52 per share2.07AMEDAmedisys$2.37B1.34$6.20 per share15.67$36.03 per share2.70BIOSBioPlus AcquisitionN/AN/AN/AN/AN/AN/ACHEChemed$2.43B2.77$25.38 per share18.11$74.35 per share6.18LHCGLHC Group$2.22B2.37$7.51 per share22.60$52.17 per share3.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$73.60M$4.4325.0420.691.596.52%9.23%6.96%8/4/2025 (Estimated)AMEDAmedisys$43.23M$2.7135.8620.081.333.79%12.52%7.01%7/23/2025 (Estimated)BIOSBioPlus AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ACHEChemed$302M$20.5322.3919.732.2412.40%27.58%18.96%7/29/2025 (Estimated)LHCGLHC Group$115.73M$2.0582.8335.2322.732.73%8.13%4.63%N/ALatest LHCG, AMED, BIOS, ADUS, and CHE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/4/2025Q2 2025ADUSAddus HomeCare$1.45N/AN/AN/A$345.71 millionN/A7/23/2025Q2 2025AMEDAmedisys$1.39N/AN/AN/A$614.61 millionN/A7/23/2025Q2 2025CHEChemed$6.02N/AN/AN/A$650.60 millionN/A5/5/2025Q1 2025ADUSAddus HomeCare$1.33$1.42+$0.09$1.16$341.66 million$337.71 million4/23/2025Q1 2025AMEDAmedisys$1.13$1.25+$0.12$1.84$597.43 million$594.78 million4/23/2025Q1 2025CHEChemed$5.59$5.63+$0.04$4.86$641.78 million$646.94 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/AAMEDAmedisysN/AN/AN/AN/AN/ABIOSBioPlus AcquisitionN/AN/AN/AN/AN/ACHEChemed$2.000.44%N/A9.74%16 YearsLHCGLHC GroupN/AN/AN/AN/AN/ALatest LHCG, AMED, BIOS, ADUS, and CHE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/20/2025CHEChemedquarterly$0.500.3%5/29/20255/29/20256/17/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCare0.201.741.74AMEDAmedisys0.271.291.29BIOSBioPlus AcquisitionN/AN/AN/ACHEChemedN/A1.731.70LHCGLHC Group0.441.451.45Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%AMEDAmedisys94.36%BIOSBioPlus Acquisition66.19%CHEChemed95.85%LHCGLHC Group83.47%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.60%AMEDAmedisys2.10%BIOSBioPlus Acquisition22.60%CHEChemed3.29%LHCGLHC Group4.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare49,70318.40 million17.55 millionOptionableAMEDAmedisys19,00032.82 million32.13 millionOptionableBIOSBioPlus AcquisitionN/A19.37 million14.99 millionNot OptionableCHEChemed15,69514.63 million14.15 millionOptionableLHCGLHC Group30,00031.03 million29.54 millionOptionableLHCG, AMED, BIOS, ADUS, and CHE HeadlinesRecent News About These CompaniesOptum, LHC Group Put Pedal Down On Home-Based Care EffortsDecember 5, 2024 | homehealthcarenews.comH3 Stocks Raising Dividends 4X Higher Than InflationSeptember 26, 2024 | finance.yahoo.comLHC orders removal of Nadra chairman citing ‘unauthorised appointment’September 8, 2024 | dawn.comDLHC orders removal of Nadra chairman citing ‘unauthorized appointment’September 8, 2024 | dawn.comDAccelerator report: LHC run 3 achieves record-breaking integrated luminositySeptember 4, 2024 | phys.orgPNew Constraints on Magnetic Monopoles from LHC ExperimentAugust 21, 2024 | msn.comNext-generation triggers for HL-LHC and beyondMay 3, 2024 | cerncourier.comCOne of Cettire’s most prominent backers has sold out entirelyApril 23, 2024 | afr.comLHC sentences lawyer to 6 months in jail for misbehaving with judgeApril 10, 2024 | dawn.comDLife Healthcare Group Holdings Ltd.February 17, 2024 | wsj.comJustice Anwaarul Haq takes oath as Chief Justice LHCJuly 31, 2023 | radio.gov.pkRUnitedHealth offers over $3 bln for home health firm AmedisysJune 5, 2023 | reuters.comJustice Muhammad Ameer Bhatti takes oath as new Chief Justice of LHCMay 27, 2023 | radio.gov.pkRLHC stops former Punjab CM Buzdar’s arrest till ThursdayMay 5, 2023 | tribune.com.pkTWhat will the Large Hadron Collider discover next?April 27, 2023 | bbc.co.ukLHC Group Stock Hits New 52-Week Low (LHCG)April 17, 2023 | thestreet.comAfter Closing On LHC Group Deal, Optum Looks To Capitalize On Home-Based Care CapabilitiesApril 15, 2023 | homehealthcarenews.comHConstruction framework provider LHC Procurement Group reinforces foundations with two key Scottish hiresApril 10, 2023 | scotsman.comSLHC Group 'more valuable' being in Lafayette in merger with UnitedHealth, co-founder saysApril 6, 2023 | theadvocate.comTLHC strikes down colonial-era sedition law that stifled free speechApril 1, 2023 | pakistantoday.com.pkPNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseSarepta Drops 42% on Fatalities; Markets Eye Solid BiosciencesBy Leo Miller | June 18, 2025View Sarepta Drops 42% on Fatalities; Markets Eye Solid BiosciencesLHCG, AMED, BIOS, ADUS, and CHE Company DescriptionsAddus HomeCare NASDAQ:ADUS$110.92 -1.28 (-1.14%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$110.88 -0.05 (-0.04%) As of 07/11/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Amedisys NASDAQ:AMED$97.18 -0.49 (-0.50%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$97.16 -0.02 (-0.02%) As of 07/11/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.BioPlus Acquisition NASDAQ:BIOSBioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.Chemed NYSE:CHE$459.69 -5.99 (-1.29%) Closing price 07/11/2025 03:58 PM EasternExtended Trading$459.54 -0.15 (-0.03%) As of 07/11/2025 05:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.LHC Group NASDAQ:LHCGLHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations. The Home Health segment offers a wide range of services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education. The Hospice Services segment offer a wide range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The Home & Community-Based Services segment are performed by paraprofessional personnel, and include assistance to the elderly, chronically ill, and disabled patients with activities of daily living. The Facility Based Services segment includes long-term acute care hospitals treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical perso More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/07 - 07/11 Power Solutions International Poised for 75% Upside The Meteoric Rise of Rocket Lab: A Space Stock to Watch Meta and Autonomous Advertising: The Stock's Next Big Tailwind? Super Micro Computer: The Hidden Winner of Soaring Copper Tariffs Nebius Group: Up 385%, Analysts Say It’s Still a Bargain Broadcom Stock: HSBC Sets $400 Target on AI Growth Potential BigBear.ai: Why a 90% Rally Could Be Just the Start Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
